2022 - Research.com Best Female Scientist Award
Stefania Pittaluga focuses on Lymphoma, Pathology, Immunology, Cancer research and Internal medicine. Stefania Pittaluga regularly ties together related areas like Germinal center in her Lymphoma studies. Her Pathology research includes themes of Fluorescence in situ hybridization, Gene rearrangement, Cancer and Cytogenetics.
The Immunology study combines topics in areas such as Hematopoietic stem cell transplantation, Transplantation and Haploinsufficiency. Her work carried out in the field of Cancer research brings together such families of science as Mutation, B cell, Signal transduction, Cyclin D3 and breakpoint cluster region. Her studies in Internal medicine integrate themes in fields like Vascular endothelial growth factor C and Oncology.
Stefania Pittaluga mainly investigates Pathology, Lymphoma, Immunology, Internal medicine and Cancer research. Stefania Pittaluga works mostly in the field of Pathology, limiting it down to topics relating to Gene rearrangement and, in certain cases, Molecular biology, as a part of the same area of interest. Her Lymphoma research incorporates themes from Epstein–Barr virus and Germinal center.
Her studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine. Her Cancer research research also works with subjects such as
Her primary areas of study are Lymphoma, Internal medicine, Cancer research, Immunology and Oncology. Her Lymphoma study results in a more complete grasp of Pathology. Her biological study spans a wide range of topics, including Diffuse alveolar damage and Chronic lymphocytic leukemia.
Her Internal medicine study frequently draws connections between adjacent fields such as Gastroenterology. Her Cancer research research is multidisciplinary, relying on both Downregulation and upregulation, Germinal center, High grade B-cell lymphoma, Antigen and Follicular lymphoma. The concepts of her Oncology study are interwoven with issues in Lenalidomide, Cytarabine, Ibrutinib, Febrile neutropenia and Prednisone.
Stefania Pittaluga focuses on Immunology, Lymphoma, Cancer research, Internal medicine and Virus. Her Immunology study frequently draws connections between related disciplines such as Saliva. Many of her research projects under Lymphoma are closely connected to Context with Context, tying the diverse disciplines of science together.
Her Cancer research study combines topics in areas such as Mutation, Histiocytosis, Adult female and Oncogene Proteins. The various areas that Stefania Pittaluga examines in her Internal medicine study include Gastroenterology and Oncology. Her Virus study combines topics from a wide range of disciplines, such as Myeloid, Complement factor B, Complement system and Pneumonia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene-Expression Profiles in Hereditary Breast Cancer
I Hedenfalk;D Duggan;Y Chen;M Radmacher.
The New England Journal of Medicine (2001)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu;Patricia Pérez-Galán;Delong Liu;Angélique Biancotto.
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson;Ryan M. Young;Roland Schmitz;Yandan Yang.
Nature Medicine (2015)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar.
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson.
The New England Journal of Medicine (2018)
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
Kieron Dunleavy;Stefania Pittaluga;Myron S. Czuczman;Sandeep S. Dave.
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Hye Sun Kuehn;Weiming Ouyang;Bernice Lo;Elissa K. Deenick;Elissa K. Deenick.
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
Lluís Colomo;Florence Loong;Susana Rives;Stefania Pittaluga.
The American Journal of Surgical Pathology (2004)
Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1
Ombretta Salvucci;Lei Yao;Sabrina Villalba;Agatha Sajewicz.
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
Amy P. Hsu;Elizabeth P. Sampaio;Javed Khan;Katherine R. Calvo.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: